Troyen A Brennan
CIK 1351402 · View on SEC EDGAR ↗
First SEC filing: May 5, 2008 · Latest: May 5, 2008
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2022 | CVS | S 10b5-1 | 47,937 | $110.00 | $5,273,070 | 138,246 Direct | -25.75% | Disposed | -14.9% (price as of 2026-08-21) |
| Nov. 1, 2021 | CVS | S | 28,159 | $90.00 | $2,534,310 | 138,246 Direct | -16.92% | Disposed | 4.0% (price as of 2026-08-21) |
| Oct. 26, 2021 | CVS | S 10b5-1 | 1,955 | $88.00 | $172,040 | 219,048 Direct | -0.88% | Disposed | 6.3% (price as of 2026-08-21) |
| Oct. 26, 2021 | CVS | S 10b5-1 | 80,802 | $88.00 | $7,110,576 | 138,246 Direct | -36.89% | Disposed | 6.3% (price as of 2026-08-21) |
| Sept. 2, 2021 | CVS | S 10b5-1 | 2,625 | $87.00 | $228,375 | 140,201 Direct | -1.84% | Disposed | 7.6% (price as of 2026-08-21) |
| June 15, 2021 | CVS | S 10b5-1 | 67,552 | $86.00 | $5,809,472 | 142,826 Direct | -32.11% | Disposed | 8.8% (price as of 2026-08-21) |
| May 7, 2021 | CVS | S 10b5-1 | 9,477 | $84.00 | $796,068 | 144,697 Direct | -6.15% | Disposed | 11.4% (price as of 2026-08-21) |
| Jan. 8, 2021 | CVS | S 10b5-1 | 58,896 | $75.00 | $4,417,200 | 46,008 Direct | -56.14% | Disposed | 24.8% (price as of 2026-08-21) |
| Nov. 4, 2019 | CVS | S 10b5-1 | 23,604 | $68.00 | $1,605,072 | 84,317 Direct | -21.87% | Disposed | 37.6% (price as of 2026-08-21) |
| Nov. 14, 2018 | CVS | S 10b5-1 | 14,229 | $82.00 | $1,166,778 | 70,494 Direct | -16.79% | Disposed | 14.1% (price as of 2026-08-21) |
| March 21, 2017 | CVS | S 10b5-1 | 16,637 | $78.73 | $1,309,831 | 77,672 Direct | -17.64% | Disposed | 18.9% (price as of 2026-08-21) |
| March 21, 2017 | CVS | S 10b5-1 | 7,212 | $78.73 | $567,801 | 70,460 Direct | -9.29% | Disposed | 18.9% (price as of 2026-08-21) |
| May 5, 2016 | CVS | S 10b5-1 | 7,517 | $105.00 | $789,285 | 69,601 Direct | -9.75% | Disposed | -10.9% (price as of 2026-08-21) |
| March 9, 2016 | CVS | S 10b5-1 | 6,755 | $100.00 | $675,500 | 69,601 Direct | -8.85% | Disposed | -6.4% (price as of 2026-08-21) |
| Oct. 27, 2015 | CVS | S 10b5-1 | 23,603 | $105.00 | $2,478,315 | 61,841 Direct | -27.62% | Disposed | -10.9% (price as of 2026-08-21) |
| April 2, 2015 | CVS | S 10b5-1 | 16,637 | $102.71 | $1,708,786 | 61,841 Direct | -21.20% | Disposed | -8.9% (price as of 2026-08-21) |
| April 1, 2015 | CVS | S 10b5-1 | 16,747 | $102.26 | $1,712,548 | 57,510 Direct | -22.55% | Disposed | -8.5% (price as of 2026-08-21) |
| March 23, 2015 | CVS | S 10b5-1 | 33,274 | $104.94 | $3,491,774 | 55,086 Direct | -37.66% | Disposed | -10.8% (price as of 2026-08-21) |
| Jan. 2, 2015 | CVS | S 10b5-1 | 50,240 | $95.71 | $4,808,470 | 41,247 Direct | -54.91% | Disposed | -2.2% (price as of 2026-08-21) |
| March 31, 2014 | CVS | S 10b5-1 | 3,456 | $75.00 | $259,200 | 33,468 Direct | -9.36% | Disposed | 24.8% (price as of 2026-08-21) |
| March 28, 2014 | CVS | S 10b5-1 | 15,411 | $74.18 | $1,143,188 | 36,924 Direct | -29.45% | Disposed | 26.2% (price as of 2026-08-21) |
| Nov. 18, 2013 | CVS | S 10b5-1 | 35,387 | $65.61 | $2,321,741 | 35,982 Direct | -49.58% | Disposed | 42.6% (price as of 2026-08-21) |
| April 15, 2013 | CVS | S 10b5-1 | 70,773 | $57.34 | $4,058,124 | 30,061 Direct | -70.19% | Disposed | 63.2% (price as of 2026-08-21) |
| April 15, 2013 | CVS | S 10b5-1 | 34,423 | $57.22 | $1,969,684 | 30,061 Direct | -53.38% | Disposed | 63.6% (price as of 2026-08-21) |
| April 15, 2013 | CVS | S 10b5-1 | 34,422 | $57.34 | $1,973,757 | 30,061 Direct | -53.38% | Disposed | 63.2% (price as of 2026-08-21) |
Showing latest 100 of 139 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 3, 2022 | CVS | Stock Option | Common Stock (47,937) | $102.26 | April 1, 2022 | 47,937 | Disposed |
| Nov. 1, 2021 | CVS | Stock Option | Common Stock (28,159) | — | April 1, 2030 | 28,159 | Disposed |
| Oct. 26, 2021 | CVS | Stock Option | Common Stock (80,802) | $54.19 | April 1, 2029 | 80,802 | Disposed |
| June 15, 2021 | CVS | Stock Option | Common Stock (65,681) | $62.21 | April 1, 2025 | 65,681 | Disposed |
| April 1, 2021 | CVS | Stock Option | Common Stock (99,344) | $74.30 | April 1, 2031 | 99,344 | Acquired |
| Jan. 8, 2021 | CVS | Stock Option | Common Stock (54,550) | $74.29 | April 1, 2021 | 54,550 | Disposed |
| April 1, 2020 | CVS | Stock Option | Common Stock (112,637) | — | April 1, 2030 | 112,637 | Acquired |
| April 1, 2020 | CVS | Stock Option | Common Stock (112,637) | — | April 1, 2030 | 112,637 | Acquired |
| Nov. 4, 2019 | CVS | Stock Option | Common Stock (23,604) | $54.53 | April 1, 2020 | 23,604 | Disposed |
| April 1, 2019 | CVS | Stock Option | Common Stock (161,605) | $54.19 | April 1, 2029 | 161,605 | Acquired |
| April 1, 2018 | CVS | Stock Option | Common Stock (87,575) | $62.21 | April 1, 2025 | 87,575 | Acquired |
| April 3, 2017 | CVS | Stock Option | Common Stock (75,134) | $78.05 | April 3, 2024 | 75,134 | Acquired |
| March 21, 2017 | CVS | Stock Option | Common Stock (16,637) | $45.07 | April 2, 2019 | 16,637 | Disposed |
| April 1, 2016 | CVS | Stock Option | Common Stock (53,772) | $104.82 | April 1, 2023 | 53,772 | Acquired |
| Oct. 27, 2015 | CVS | Stock Option | Common Stock (23,603) | $54.53 | April 1, 2020 | 23,603 | Disposed |
| April 2, 2015 | CVS | Stock Option | Common Stock (16,637) | $45.07 | April 2, 2019 | 16,637 | Disposed |
| April 1, 2015 | CVS | Stock Option | Common Stock (47,937) | $102.26 | April 1, 2022 | 47,937 | Acquired |
| April 1, 2015 | CVS | Stock Option | Common Stock (16,747) | $34.96 | April 1, 2018 | 16,747 | Disposed |
| March 23, 2015 | CVS | Stock Option | Common Stock (33,274) | $45.07 | April 2, 2019 | 33,274 | Disposed |
| Jan. 2, 2015 | CVS | Stock Option | Common Stock (50,240) | $34.96 | April 1, 2018 | 50,240 | Disposed |
| April 1, 2014 | CVS | Stock Option | Common Stock (54,550) | $74.29 | April 1, 2021 | 54,550 | Acquired |
| Nov. 18, 2013 | CVS | Stock Option | Common Stock (35,387) | $28.26 | Nov. 17, 2018 | 35,387 | Disposed |
| April 15, 2013 | CVS | Stock Option | Common Stock (70,773) | $28.26 | Nov. 17, 2018 | 70,773 | Disposed |
| April 15, 2013 | CVS | Stock Option | Common Stock (34,423) | $36.23 | April 1, 2017 | 34,423 | Disposed |
| April 15, 2013 | CVS | Stock Option | Common Stock (34,422) | $36.23 | April 1, 2017 | 34,422 | Disposed |
| April 1, 2013 | CVS | Stock Option | Common Stock (47,207) | $54.53 | April 1, 2020 | 47,207 | Acquired |
| March 19, 2013 | CVS | Stock Option | Common Stock (6,222) | $36.23 | April 1, 2017 | 6,222 | Disposed |
| March 18, 2013 | CVS | Stock Option | Common Stock (28,200) | $36.23 | April 1, 2017 | 28,200 | Disposed |
| April 2, 2012 | CVS | Stock Option | Common Stock (66,548) | $45.07 | April 2, 2019 | 66,548 | Acquired |
| April 2, 2012 | CVS | Stock Option | Common Stock (48,178) | $28.10 | April 1, 2016 | 48,178 | Disposed |
| Feb. 21, 2012 | CVS | Stock Option | Common Stock (96,354) | $28.10 | April 1, 2016 | 96,354 | Disposed |
| April 1, 2011 | CVS | Stock Option | Common Stock (66,987) | $34.96 | April 1, 2018 | 66,987 | Acquired |
| April 1, 2010 | CVS | Stock Option | Common Stock (103,267) | $36.23 | April 1, 2017 | 103,267 | Acquired |
| April 1, 2009 | CVS | Stock Option | Common Stock (144,532) | $28.10 | April 1, 2016 | 144,532 | Acquired |
| Nov. 17, 2008 | CVS | Stock Option | Common Stock (106,160) | $28.26 | Nov. 17, 2018 | 106,160 | Acquired |
| May 1, 2008 | 1122304 | Restricted Stock Units | Common Stock (22,452) | — | — | 22,452 | Acquired |
| Feb. 11, 2008 | 1122304 | Restricted Stock Units | Common Stock (4,111) | — | — | 4,111 | Disposed |
| Feb. 8, 2008 | 1122304 | Stock Appreciation Right | Common Stock (85,142) | $50.70 | Feb. 8, 2018 | 85,142 | Acquired |
| Feb. 9, 2007 | 1122304 | Restricted Stock Units | Common Stock (12,333) | — | — | 12,333 | Acquired |
| Feb. 9, 2007 | 1122304 | Stock Appreciation Right | Common Stock (86,414) | $42.57 | Feb. 9, 2017 | 86,414 | Acquired |
| Feb. 21, 2006 | 1122304 | Restricted Stock Units | Common Stock (9,053) | — | — | 9,053 | Acquired |
| Feb. 21, 2006 | 1122304 | Stock Appreciation Right | Common Stock (64,201) | $49.71 | Feb. 21, 2016 | 64,201 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CVS
EVP| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2013 | $637,500 | — | — | — | $2,353,457 | — | — | $5,022,695 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.